Applied DNA Sciences Inc - APDN Earnings growth forecast for next year
Applied DNA Sciences (APDN) leverages its proprietary LinearDNA ecosystem to protect B2B contracts from supplier switching, although geopolitical tensions driving demand for DNA tagging may restrict equipment imports. Expected EPS dynamics for the next period demonstrate a trend where the value of 0.00 fixes the metric level. In production, Applied DNA Sciences (APDN) is implementing AI-driven robotics for enzymatic synthesis, fully automating bioreactors to eliminate defects.
Applied DNA Sciences Inc - analytical breakdowns and key metrics (APDN)
- stock quotes and analyst forecast:
- issuer market value details:
- book capitalization indicators:
- debt obligations and liquidity statistics:
Total Debt to Equity Ratio Applied DNA Sciences|APDN - Long-Term Debt to Capital Coefficient|Short-Term Debt to Equity Applied DNA Corp|APDN - Company Total Debt Obligations|Debts to Book Capitalization Applied DNA|APDN - Company Long-Term Liabilities|Company Short-Term Debts Applied DNA Sciences|Quick Ratio adnas.com
- net income and valuation ratios data:
APDN - Company Net Income|Expected Profit Applied DNA Sciences|APDN - Price to Earnings Multiple|Forward P/E Multiple Applied DNA Sciences Inc|APDN - Price/Earnings to Growth Multiple|EV/EBITDA Multiple Applied DNA Sciences|APDN - Profit before interest, taxes and amortization|Earnings per share for the last twelve months Applied DNA Sciences|APDN - Net earnings per share for the last four quarters|Quarterly EPS earnings growth adnas.com|APDN - Earnings growth in current year|Net earnings per share growth forecast for next year Applied DNA Sciences
- issuer revenue and sales details:
Initial company analysis:adnas.com, APDN
This indicator is calculated as the percentage change in the consensus earnings per share (EPS) forecast between the current and next reporting year, allowing market noise to be filtered out from the long-term fundamental trend. For Applied DNA Sciences (APDN), the projected EPS growth for the coming year reflects the monetization potential of DNA tagging in pharmaceuticals and textiles, transforming technological supply chain protection into tangible financial results.
Analysis of competing companies
TEM (Tempus) - Earnings growth forecast for next year|Projected earnings per share growth rate for next year QGEN (Qiagen)|Earnings growth forecast for next year IONS|RGEN (Repligen) - Expected earnings per share trend next year|Net earnings per share growth forecast for next year aviditybiosciences.com RNA|CRISPR (CRSP) - Expected net earnings per share growth next year|genedx.com - Earnings growth forecast for next year|Expected earnings per share trend next year RARE (ultragenyx.com)|BEAM: Earnings growth forecast for next year|Sarepta - Expected earnings per share trend next year|TWST (twistbioscience.com) - Earnings growth forecast for next year|Projected earnings per share growth rate for next year TXG (10x Genomics Corp)|Earnings growth forecast for next year NTLA|Earnings growth forecast for next year Stoke Therapeutics, Inc. (STOK)|Net earnings per share growth forecast for next year BioLife BLFS|WVE - Expected earnings per share growth for next year|Maze Therapeutics Corp - Earnings growth forecast for next year|Sionna Pharma - Projected earnings per share increase next year|Prime Medicine (PRME) - Net earnings per share growth forecast for next year|tayshagtx.com (TSHA) - Earnings growth forecast for next year|Net earnings per share growth forecast for next year uniQure Corp|MGTX: Expected earnings per share trend next year|Earnings growth forecast for next year RGNX|Consensus forecast of earnings per share growth for next year Solid Corp|Earnings growth forecast for next year OCGN (ocugen.com)|PACB (Pacific Biosciences) - Net earnings per share change forecast for next year|Benitec Biopharma Inc - Earnings growth forecast for next year|Consensus forecast of earnings per share growth for next year Design Therapeutics, Inc. DSGN|Rocket Corp (RCKT) - Net earnings per share growth forecast for next year|4D Molecular Therapeutics (FDMT) - Earnings growth forecast for next year|LXEO (Lexeo Therapeutics, Inc.) - Earnings growth forecast for next year|Expected net earnings per share growth next year korrobio.com KRRO|Expected earnings per share growth for next year EDIT (Editas Medicine, Inc.)|Silence Therapeutics plc - Projected earnings per share growth rate for next year|Net earnings per share growth forecast for next year ProQR Therapeutics N.V. PRQR|Consensus forecast of earnings per share growth for next year Codexis, Inc. (CDXS)|SGMO - Net earnings per share growth forecast for next year|nautilus.bio - Projected earnings per share increase next year|Metagenomi, Inc (MGX) - Net earnings per share growth forecast for next year|Projected earnings per share growth rate for next year DTIL|Net earnings per share growth forecast for next year Generation Bio|Earnings growth forecast for next year Boundless Bio Inc|Net earnings per share growth forecast for next year Exicure Corp (XCUR)|Consensus forecast of earnings per share growth for next year Imunon|Earnings growth forecast for next year PHIO (phiopharma.com)|Net earnings per one share growth forecast for next year mustangbio.com|RNAZ - Net earnings per share growth forecast for next year|Expected net earnings per share growth next year Bionano Genomics|BLUE: Earnings growth forecast for next year|Expected earnings per share growth for next year ImmunoPrecise Antibodies|OMGA (Omega Therapeutics, Inc.) - Earnings growth forecast for next year|Singular Genomics (OMIC) - Consensus forecast of earnings per share growth for next year|Net earnings per share growth forecast for next year Regulus (RGLS)|SYRS (Syros Pharmaceuticals, Inc) - Expected earnings per share trend next year|Telesis Bio, Inc. - Expected earnings per share growth for next year|TCON: Projected earnings per share growth rate for next year|Unity Biotechnology Inc. - Earnings growth forecast for next year
